title: [Difficulties in echocardiographic monitoring of trastuzumab therapy in breast cancer patients: case report and review of recommendations].
authors.affiliation: Klinika Onkologii, Wojskowy Instytut, Medyczny, Warszawa, Poland.
authors.forename: Renata
authors.initials: R
authors.lastname: Duchnowska
authors.forename: Sebastian
authors.initials: S
authors.lastname: Szmit
authors.forename: Cezary
authors.initials: C
authors.lastname: Szczylik
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Opolski
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D016903:Drug Monitoring; D004452:Echocardiography; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D006801:Humans; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab